A Philadelphia company that specializes in three-dimensional bioprinting is teaming up with The Wistar Institute on a research collaboration targeting Covid-19.
Allevi Inc. and Wistar plan to evaluate how Allevi's 3D biofabrication technologies could be useful in the the battle against the new coronavirus strain.
